Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry

Background/Aim: To determine the yield of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in combination with immunostains in diagnosing unusual solid pancreatic masses (USPM) in comparison with pancreatic adenocarcinoma (ACP). Patients and Methods: All EUS-FNA of solid pancreatic mass...

Full description

Bibliographic Details
Main Authors: Mohamad A Eloubeidi, Ashutosh R Tamhane, James L Buxbaum
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2012;volume=18;issue=2;spage=99;epage=105;aulast=Eloubeidi
_version_ 1819174874056228864
author Mohamad A Eloubeidi
Ashutosh R Tamhane
James L Buxbaum
author_facet Mohamad A Eloubeidi
Ashutosh R Tamhane
James L Buxbaum
author_sort Mohamad A Eloubeidi
collection DOAJ
description Background/Aim: To determine the yield of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in combination with immunostains in diagnosing unusual solid pancreatic masses (USPM) in comparison with pancreatic adenocarcinoma (ACP). Patients and Methods: All EUS-FNA of solid pancreatic masses performed with a 22-gauge needle were included. Data on clinical presentations, mass characteristics, presence of pancreatitis, yield of tissue, and final diagnosis were compared between the two groups. On site cytopathology was provided and additional passes were requested to perform immunostains. Results : Two hundred and twenty-nine cases with either adenocarcinoma or USPM were included. The median age of the cohort was 65 years. ACP (210/229, 92%) accounted for the majority of the cases. The USPM included neuroendocrine (NET) masses (n=13), metastatic renal carcinoma (n=3), metastatic melanoma (n=1), lymphoma (n=1), and malignant fibrous histiocytoma (n=1). Subjects with ACP were significantly more likely to present with loss of weight (P=0.02) or obstructive jaundice (P<0.001). Subjects with ACP were more likely to have suspicious/atypical FNA biopsy results as compared with USPM (10% vs 0%). The sensitivity of EUS-FNA with immunostains was 93% in ACP as compared with 100% in USPM. Diagnostic accuracy was higher in USPM as compared with ACP (100% vs 93%). Conclusions: EUS-FNA using a 22-gauge needle with immunostains has excellent diagnostic yield in patients with USPMs, which is comparable if not superior to the yield in pancreatic adenocarcinoma.
first_indexed 2024-12-22T20:45:54Z
format Article
id doaj.art-0b0d957ee73844ddb3b5ce11f4063c71
institution Directory Open Access Journal
issn 1319-3767
1998-4049
language English
last_indexed 2024-12-22T20:45:54Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series The Saudi Journal of Gastroenterology
spelling doaj.art-0b0d957ee73844ddb3b5ce11f4063c712022-12-21T18:13:14ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492012-01-011829910510.4103/1319-3767.93810Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistryMohamad A EloubeidiAshutosh R TamhaneJames L BuxbaumBackground/Aim: To determine the yield of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in combination with immunostains in diagnosing unusual solid pancreatic masses (USPM) in comparison with pancreatic adenocarcinoma (ACP). Patients and Methods: All EUS-FNA of solid pancreatic masses performed with a 22-gauge needle were included. Data on clinical presentations, mass characteristics, presence of pancreatitis, yield of tissue, and final diagnosis were compared between the two groups. On site cytopathology was provided and additional passes were requested to perform immunostains. Results : Two hundred and twenty-nine cases with either adenocarcinoma or USPM were included. The median age of the cohort was 65 years. ACP (210/229, 92%) accounted for the majority of the cases. The USPM included neuroendocrine (NET) masses (n=13), metastatic renal carcinoma (n=3), metastatic melanoma (n=1), lymphoma (n=1), and malignant fibrous histiocytoma (n=1). Subjects with ACP were significantly more likely to present with loss of weight (P=0.02) or obstructive jaundice (P<0.001). Subjects with ACP were more likely to have suspicious/atypical FNA biopsy results as compared with USPM (10% vs 0%). The sensitivity of EUS-FNA with immunostains was 93% in ACP as compared with 100% in USPM. Diagnostic accuracy was higher in USPM as compared with ACP (100% vs 93%). Conclusions: EUS-FNA using a 22-gauge needle with immunostains has excellent diagnostic yield in patients with USPMs, which is comparable if not superior to the yield in pancreatic adenocarcinoma.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2012;volume=18;issue=2;spage=99;epage=105;aulast=EloubeidiCytologyendoscopic ultrasoundfine needle aspirationimmunostainsmetastasisneuroendocrine tumorspancreas
spellingShingle Mohamad A Eloubeidi
Ashutosh R Tamhane
James L Buxbaum
Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
The Saudi Journal of Gastroenterology
Cytology
endoscopic ultrasound
fine needle aspiration
immunostains
metastasis
neuroendocrine tumors
pancreas
title Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
title_full Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
title_fullStr Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
title_full_unstemmed Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
title_short Unusual, metastatic, or neuroendocrine tumor of the pancreas: A diagnosis with endoscopic ultrasound-guided fine-needle aspiration and immunohistochemistry
title_sort unusual metastatic or neuroendocrine tumor of the pancreas a diagnosis with endoscopic ultrasound guided fine needle aspiration and immunohistochemistry
topic Cytology
endoscopic ultrasound
fine needle aspiration
immunostains
metastasis
neuroendocrine tumors
pancreas
url http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2012;volume=18;issue=2;spage=99;epage=105;aulast=Eloubeidi
work_keys_str_mv AT mohamadaeloubeidi unusualmetastaticorneuroendocrinetumorofthepancreasadiagnosiswithendoscopicultrasoundguidedfineneedleaspirationandimmunohistochemistry
AT ashutoshrtamhane unusualmetastaticorneuroendocrinetumorofthepancreasadiagnosiswithendoscopicultrasoundguidedfineneedleaspirationandimmunohistochemistry
AT jameslbuxbaum unusualmetastaticorneuroendocrinetumorofthepancreasadiagnosiswithendoscopicultrasoundguidedfineneedleaspirationandimmunohistochemistry